Total Assets (Quarterly) Chart

View Total Assets (Quarterly) for MGTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Assets (Quarterly) Chart
Start Trial

Historical Total Assets (Quarterly) Data

View and export this data back to 2018. Start Trial.
Date Value
June 30, 2026 396.45M
March 31, 2026 244.66M
December 31, 2025 251.04M
September 30, 2025 189.47M
June 30, 2025 198.72M
March 31, 2025 224.01M
December 31, 2024 269.75M
September 30, 2024 299.49M
June 30, 2024 266.65M
March 31, 2024 309.24M
December 31, 2023 458.17M
September 30, 2023 267.19M
June 30, 2023 310.26M
March 31, 2023 288.14M
December 31, 2022
September 30, 2022 301.41M
June 30, 2022 252.46M
Date Value
March 31, 2022 287.69M
December 31, 2021 320.16M
September 30, 2021 303.34M
June 30, 2021 326.77M
March 31, 2021 339.68M
December 31, 2020 363.70M
September 30, 2020 293.05M
June 30, 2020 290.61M
March 31, 2020 304.67M
December 31, 2019 323.89M
September 30, 2019 317.75M
June 30, 2019 253.08M
March 31, 2019 257.85M
December 31, 2018 96.89M
September 30, 2018 105.24M
June 30, 2018 117.68M
March 31, 2018 50.78M

Total Assets Definition

Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.

Read full definition.

Total Assets (Quarterly) Range, Past 5 Years

View Total Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Assets (Quarterly) Benchmarks

View Total Assets (Quarterly) Benchmarks
Start Trial
Xencor, Inc. 724.96M
UroGen Pharma Ltd. 252.59M
IDEAYA Biosciences, Inc. 1.310B
ACADIA Pharmaceuticals, Inc. 1.743B
Alnylam Pharmaceuticals, Inc. 5.559B

Total Assets (Quarterly) Related Metrics